Genetic composition of replication competent clonal HIV-1 variants isolated from peripheral blood mononuclear cells (PBMC), HIV-1 proviral DNA from PBMC and HIV-1 RNA in serum in the course of HIV-1 infection

Virology

Volumn 405, Issue 2, 2010, Pages 492-504

  Edo Matas, Diana ^a   van Gils, Marit J ^a   Bowles, Emma J ^b   Navis, Marjon ^a   Rachinger, Andrea ^a   Boeser Nunnink, Brigitte ^a   Stewart Jones, Guillaume B ^b   Kootstra, Neeltje A ^a   van 't Wout, Angélique B ^a   Schuitemaker, Hanneke ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CCR5; Clonal HIV 1 variants; CXCR4; HIV 1; PBMC; Plasma; Viral quasispecies

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 160; VIRUS DNA; VIRUS RNA;

ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE COURSE; DNA ISOLATION; DNA SYNTHESIS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC DISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOLECULAR CLONING; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ISOLATION; VIRAL GENETICS; VIRUS ISOLATION; VIRUS REPLICATION;

CD4 LYMPHOCYTE COUNT; CLONING, MOLECULAR; DNA, VIRAL; GENETIC VARIATION; HIV ENVELOPE PROTEIN GP160; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; PROVIRUSES; RECEPTORS, CCR5; RECEPTORS, CXCR4; RNA, VIRAL; VIRAL LOAD; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77955653140     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.06.029     Document Type: Article

References (49)

1. Bou-Habib D.C., et al. Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J. Virol. 1994, 68:6006-6013.
2. Bunnik E.M., Quakkelaar E.D., van Nuenen A.C., Boeser-Nunnink B., Schuitemaker H. Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient. J. Virol. 2007, 81:525-531.
3. Callaway D.S., Ribeiro R.M., Nowak M.A. Virus phenotype switching and disease progression in HIV-1 infection. Proc. Biol. Sci. 1999, 266:2523-2530.
4. Cheng-Mayer C., Homsy J., Evans L.A., Levy J.A. Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:2815-2819.
5. Chun T.W., et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997, 387:183-188.
6. Chun T.W., et al. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:8869-8873.
7. Chun T.W., et al. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat. Med. 1995, 1:1284-1290.
8. Cornelissen M., et al. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium inducing/SI phenotypically mixed human immunodeficiency virus population. J. Virol. 1995, 69:1810-1818.
9. Critchlow D.E., Li S.Y., Nourijelyani K., Pearl D.K. Some statistical methods for phylogenetic trees with application to HIV disease. Math. Comput. Model. 2000, 32:69-81.
10. Falk L.A., Paul D., Landay A., Kessler H. HIV isolation from plasma of HIV-infected persons. N. Engl. J. Med. 1987, 316:1547-1548.
11. Finzi D., et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
12. Geskus R.B. On the inclusion of prevalent cases in HIV/AIDS natural history studies through a marker-based estimate of time since seroconversion. Stat. Med. 2000, 19:1753-1769.
13. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids. Symp. Ser. 1999, 41:95-98.
14. Hasegawa M., Kishino H., Yano T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J. Mol. Evol. 1985, 22:160-174.
15. Ho D.D., et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
16. Hollinger F.B., Bremer J.W., Myers L.E., Gold J.W., McQuay L. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories. J. Clin. Microbiol. 1992, 30:1787-1794.
17. Hudson R.R. A new statistic for detecting genetic differentiation. Genetics 2000, 155:2011-2014.
18. Hudson R.R., Boos D.D., Kaplan N.L. A statistical test for detecting geographic subdivision. Mol. Biol. Evol. 1992, 9:138-151.
19. Hudson R.R., Slatkin M., Maddison W.P. Estimation of levels of gene flow from DNA sequence data. Genetics 1992, 132:583-589.
20. Jensen M.A., Coetzer M., Van't Wout A.B., Morris L., Mullins J.I. A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences. J. Virol. 2006, 80:4698-4704.
21. Jensen M.A., et al. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J. Virol. 2003, 77:13376-13388.
22. Koot M., et al. Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. J. Infect. Dis. 1996, 173:349-354.
23. Koot M., et al. HIV-1 biological phenotype in long term infected individuals, evaluated with an MT-2 cocultivation assay. AIDS 1992, 6:49-54.
24. Kootstra N.A., Schuitemaker H. Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of GAG and Vpr is comparable to wild type HIV-1 in primary macrophages. Virology 1999, 253:170-180.
25. Kusumi K., et al. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J. Virol. 1992, 66:875-885.
26. Levy J.A., et al. Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Clinical, biological, and molecular features. Ann. Intern. Med. 1985, 103:694-699.
27. Meyerhans A., et al. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 1989, 58:901-910.
28. Michaelis B.A., Levy J.A. Recovery of human immunodeficiency virus from serum. JAMA 1987, 257:1327.
29. Mittler J.E., Markowitz M., Ho D.D., Perelson A.S. Improved estimates for HIV-1 clearance rate and intracellular delay. AIDS 1999, 13:1415-1417.
30. Posada D., Crandall K.A. Modeltest: testing the model of DNA substitution. Bioinformatics 1998, 14:817-818.
31. Preston B.D., Poiesz B.J., Loeb L.A. Fidelity of HIV-1 reverse transcriptase. Science 1988, 242:1168-1171.
32. Roberts J.D., Bebenek K., Kunkel T.A. The accuracy of reverse transcriptase from HIV-1. Science 1988, 242:1171-1173.
33. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 1987, 4:406-425.
34. Salahuddin S.Z., et al. Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proc. Natl Acad. Sci. U. S. A. 1985, 82:5530-5534.
35. Schuitemaker H., et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 1992, 66:1354-1360.
36. Sing T., et al. Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antivir. Ther. 2007, 12:1097-1106.
37. Slatkin M. Isolation by distance in equilibrium and nonequilibrium populations. Evolution 1993, 47:264-279.
38. Slatkin M., Maddison W.P. A cladistic measure of gene flow inferred from the phylogenies of alleles. Genetics 1989, 123:603-613.
39. Spira A.I., Ho D.D. Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro. J. Virol. 1995, 69:422-429.
40. Swofford D.L. PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods), version 4 2002, Sinauer Associates, Sunderland, Massachusetts.
41. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 2007, 24:1596-1599.
42. Tersmette M., et al. Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV-p24 gag. Virology 1989, 171:149-155.
43. Van't Wout A.B., Schuitemaker H., Kootstra N.A. Isolation and propagation of HIV-1 on peripheral blood mononuclear cells. Nat. Protoc. 2008, 3:363-370.
44. Verhofstede C., et al. CXCR4-using HIV type 1 variants are more commonly found in peripheral blood mononuclear cell DNA than in plasma RNA. J. Acquir. Immune Defic. Syndr. 2009, 50:126-136.
45. Voronin Y., Chohan B., Emerman M., Overbaugh J. Primary isolates of human immunodeficiency virus type 1 are usually dominated by the major variants found in blood. J. Virol. 2007, 81:10232-10241.
46. Wang T.H., Donaldson Y.K., Brettle R.P., Bell J.E., Simmonds P. Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J. Virol. 2001, 75:11686-11699.
47. Wei X., et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
48. Wong J.K., et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997, 278:1291-1295.
49. Zarate S., Pond S.L., Shapshak P., Frost S.D. Comparative study of methods for detecting sequence compartmentalization in human immunodeficiency virus type 1. J. Virol. 2007, 81:6643-6651.